Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Mismatch Repair01:20

Mismatch Repair

4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
Cancer Prevention02:59

Cancer Prevention

6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Geographic and Social Equity in Population-Wide Genomic Screening.

JAMA network open·2026
Same author

Sex differences in stress responding in a randomized, placebo-controlled clinical trial of progesterone in cannabis use disorder.

Psychopharmacology·2026
Same author

Who declines genetic counseling? An assessment of genetic counseling declination among individuals participating in a population-wide genomic screening program.

Patient education and counseling·2026
Same author

Histopathological and duplex characteristics of deep venous stents: A novel microsurgical small animal model.

Vascular medicine (London, England)·2026
Same author

An exploratory mixed-methods study using the ELICIT framework to identify stakeholder-informed implementation strategies for a population health platform.

BMC health services research·2026
Same author

What it Takes to Implement Population-Based Genomic Screening: A Multi-Site Qualitative Study of Implementation Determinants Across Health Systems.

Research square·2026

Related Experiment Video

Updated: Jul 14, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K

Implementation Mapping for Managing Patients at High Risk for Hereditary Cancer.

Caitlin G Allen1, Colleen Donahue2, Emma Coen1

  • 1Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, South Carolina.

American Journal of Preventive Medicine
|October 8, 2023
PubMed
Summary

A new clinical management strategy was developed to improve care for individuals with hereditary cancer risks. This approach addresses challenges in managing pathogenic variants and enhances guideline adherence for high-risk patients.

More Related Videos

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.0K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

9.8K

Related Experiment Videos

Last Updated: Jul 14, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.0K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

9.8K

Area of Science:

  • Oncology
  • Genetics
  • Healthcare Management

Background:

  • Lack of standardized workflows for managing patients with pathogenic variants leads to challenges in hereditary cancer care.
  • Poor guideline adherence is common in individuals at high risk for hereditary cancers due to complex follow-up care.
  • Developing effective clinical management strategies is crucial for improving outcomes in hereditary cancer patients.

Purpose of the Study:

  • To create and evaluate clinical management strategies for individuals identified at high risk for hereditary cancers.
  • To establish a Hereditary Cancer Clinic using an implementation mapping approach.
  • To address logistical challenges and improve guideline adherence in hereditary cancer patient management.

Main Methods:

  • An implementation mapping approach was employed, involving a 5-step process: needs assessment, objective identification, strategy selection, protocol development, and evaluation planning.
  • Qualitative interviews with patients, specialists, and the implementation team were conducted to identify barriers and facilitators.
  • The Consolidated Framework for Implementation Research was used for coding interview data.

Main Results:

  • A Hereditary Cancer Clinic was established at the Medical University of South Carolina in 2022.
  • Implementation protocols were developed to address identified barriers and facilitators.
  • A long-term evaluation plan was created to assess implementation, service, and clinical/patient outcomes.

Conclusions:

  • The developed approach facilitates real-time enhancements in care for high-risk hereditary cancer patients.
  • Findings support improved patient management and outcomes through structured strategies for care specialists and patients.
  • The approach allows for long-term evaluation of implementation strategies and guidelines for hereditary cancer management.